about
Environmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials.The Staphylococcus aureus FASII bypass escape route from FASII inhibitors.Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.Finding sRNA-associated phenotypes by competition assays: An example with Staphylococcus aureus.Assessment of Bona Fide sRNAs in Staphylococcus aureus.The conserved regulatory RNA RsaE down-regulates the arginine degradation pathway in Staphylococcus aureusPermissive Fatty Acid Incorporation Promotes Staphylococcal Adaptation to FASII Antibiotics in Host Environments
P50
Q37329885-ED6AA157-EE54-4791-BAD9-A546451488B6Q39448603-EBC9254C-EC68-4C9A-BE68-1DD5EDEEDF59Q40334483-AC92D296-AA71-4502-BAFE-B9B4745FAAF6Q48913352-5AE96873-205D-4762-AC1B-8FB552E30EE1Q52363796-65006565-65B6-4806-9047-567D59DBDEA4Q62061825-22100025-9EFA-4D39-9597-232D57C17130Q92087440-203F5396-CFCA-476B-B873-EAFED8C57856
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claire Morvan
@ast
Claire Morvan
@en
Claire Morvan
@es
Claire Morvan
@nl
type
label
Claire Morvan
@ast
Claire Morvan
@en
Claire Morvan
@es
Claire Morvan
@nl
prefLabel
Claire Morvan
@ast
Claire Morvan
@en
Claire Morvan
@es
Claire Morvan
@nl
P106
P31
P496
0000-0001-8435-0523